G-20 summit ends with support for COVID-19 vaccines for all
Leaders of the world's most powerful nations wrapped up the Group of 20 summit on Nov. 22, vowing to spare no effort to protect lives and ensure affordable access to COVID-19 vaccines for all people.
The two-day summit of heads of state was held virtually due to the coronavirus pandemic, which has killed at least 1.38 million people globally, with the world's highest death tolls recorded in seven of the G-20 countries. The virus has wiped out hundreds of millions of jobs globally and plunged millions into extreme poverty.
The virus "revealed vulnerabilities in our preparedness and response and underscored our common challenges," the G-20 said in a final statement that focused heavily on battling the coronavirus, enhancing environmental protections and supporting the global economy.
The group vowed "to spare no effort to protect lives."
The G-20, which includes the U.S., India, China, the U.K., France, Germany, Japan and others, also stressed the importance of global access to COVID-19 vaccines, drugs and tests.
"We will spare no effort to ensure their affordable and equitable access for all people, consistent with members' commitments to incentivize innovation," the statement said.
The G-20 expressed support for efforts like COVAX, an international initiative to distribute COVID-19 vaccines to countries worldwide. The U.S., however, has declined to join under President Donald Trump.
German Chancellor Angela Merkel told reporters on Nov. 22 in Berlin after the virtual summit that Germany had given financial support to the COVAX initiative, but that more money was needed.
The G-20 statement did not directly address an urgent appeal by U.N. Secretary-General Antonio Guterres, who said $28 billion in additional...